Today, IVF has a success rate of more than 50 percent, a dramatic leap from under 10 percent in 1980. Advances in genetic testing, embryo freezing and smarter stimulation protocols have made treatment more effective than ever. In many ways, it’s nothing short of miraculous. We’ve learned to do what nature sometimes can’t.
Yet one thing hasn’t changed much: the cost. Despite decades of innovation, the average price of an IVF cycle has stayed painfully high. It’s an uncomfortable truth in a field built around hope. Fertility care is advancing, but access is not.
Among women under 35 who undergo IVF, the average live-birth rate is now around 55 percent per cycle, according to the Society for Assisted Reproductive Technology (SART). Success has improved across nearly every age group as techniques continue to evolve. IVF is no longer experimental or exceptional — it’s the established standard for family building. So why hasn’t affordability advanced at the same pace as success?
In most industries, better outcomes bring lower prices. In fertility care, the opposite is true. Efficiency and scale have grown, but affordability has not. The reason is simple: the system rewards exclusivity. The consolidation of large clinic groups has created an economic model that values scarcity over access.
The fertility industry has mastered the science of conception but ignored the economics of compassion.
Some believe policy change or expanded insurance coverage will fix this. I don’t. Coverage can help, but it won’t incentivize efficiency or lower costs. We’ve seen it across healthcare — adding layers doesn’t make care more affordable.
At Pozitivf Fertility, we decided to take a different approach. We built a model that prioritizes transparency, team-based efficiency, and patient-first design. By removing unnecessary costs and complexity, we make IVF more equitable and attainable.
Because when it comes to building families, no one should be priced out of possibility.
The future of fertility care shouldn’t just be measured in pregnancy rates. It should be measured in access — in how many people finally get the chance to experience what science now makes possible.
Join the Conversation
We welcome your thoughts in the comment section or in person. Come for a tour of Pozitivf Fertility — we’d be proud to show you everything.
